The highest estimate is 30.00. From 6 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow LXEO.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Lexeo Therapeutics, Inc. operates as a clinical-stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene therapy candidate for the treatment of arrhythmogenic cardiomyopathy; LX2021, a gene therapy candidate for the treatment of DSP cardiomyopathy associated with it; and LX2022, a gene therapy candidate for the treatment of HCM caused by TNNI3 mutations. It also develops LX1001, an AAVrh10-based gene therapy candidate for the treatment of APOE4 homozygous; LX1020, a gene therapy candidate for the treatment of APOE4 homozygous; LX1021 for the treatment of APOE4 homozygotes; and LX1004 for the treatment of CLN2 Batten disease. The company was incorporated in 2017 and is based in New York, New York.
The current price of LXEO.BOATS is $5.52 USD — it has decreased by -6.91% in the past 24 hours. Watch Lexeo Therapeutics stock price performance more closely on the chart.
What is Lexeo Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Lexeo Therapeutics stocks are traded under the ticker LXEO.BOATS.
What is Lexeo Therapeutics market cap?▼
Today Lexeo Therapeutics has the market capitalization of 402.89M
When is the next Lexeo Therapeutics earnings date?▼
Lexeo Therapeutics is going to release the next earnings report on May 07, 2026.
What were Lexeo Therapeutics earnings last quarter?▼
LXEO.BOATS earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.52 USD resulting in a +36.54% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Lexeo Therapeutics revenue for the last year?▼
Lexeo Therapeutics revenue for the last year amounts to 0 USD.
What is Lexeo Therapeutics net income for the last year?▼
LXEO.BOATS net income for the last year is -196.67M USD.
When did Lexeo Therapeutics complete a stock split?▼
Lexeo Therapeutics has not had any recent stock splits.